Brittany Craiglow, MD, FAAD, dermatologist at the Dermatology Physicians of Connecticut in Fairfield, discussed combination therapies for pediatric alopecia areata, emphasizing the benefits of ...

Brittany Craiglow, MD, FAAD, analyzed the promising use of baricitinib for severe pediatric alopecia areata. She highlighted late-breaking data from the BRAVE-AA-PEDS study (NCT05723198 ...

eyebrows and eyelashes compared with placebo in adolescents with severe alopecia areata, data show. ORLANDO — Atopic dermatitis disease activity remained mild after patients treated with Vtama ...

We know that alopecia areata is often an incredibly difficult ... Additionally, baricitinib has a legacy of safety in pediatric patients and is approved in many countries down to age 2 years ...

Dr Myro Figura, an anesthesiologist from Los Angeles, has shared a video on Instagram explaining why you might want to avoid ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

The doll is a popular toy for children, but it also has name recognition among adults and is a fashion icon. Dressing Licca-chan with a headscarf that alopecia areata patients use would also send ...

Medscape Medical News, May 31, 2024 Dupilumab: Future Treatment for Pediatric Alopecia Areata? Dupilumab will be compared with placebo in a larger multicenter randomized trial of children with ...

Eli Lilly LLY and partner Incyte INCY announced that a late-stage study evaluating oral baricitinib in adolescent patients (aged 12-18) with severe alopecia areata (AA) showed clinically ...